Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced financial and operating results for the fourth quarter and full year ended December 31, 2013 and other business updates, including the Company’s financial outlook for 2014. The fourth quarter does not include results for the Company’s acquisition of Santarus, which closed on January 2, 2014.
Help employers find you! Check out all the jobs and post your resume.
